Specialty guide · India

Pathology

Diagnostic demand, laboratory career models, cancer and molecular medicine, digital pathology and AI.

Pathology career guide
Training routeMD / DNB
NMC seats3,343
Review date31 Oct 2026

Pathology as a career

Pathology sits at the center of diagnostic medicine. Career options include hospital laboratories, diagnostic chains, academic departments, molecular diagnostics, oncology, laboratory leadership, research and increasingly digital pathology.

1.41mNew cancer cases in India in GLOBOCAN 2022.
3,343NMC MD Pathology seats in the 2026–27 matrix.
192 post-MBBS · 102 post-diplomaCurrent NBEMS DNB seats: post-MBBS and post-diploma.

Clinical demand

India recorded about 1.41 million new cancer cases in GLOBOCAN 2022, while routine pathology also spans hematology, histopathology, cytology and laboratory medicine. Demand therefore comes from both high-volume routine diagnostics and increasingly specialized oncology and molecular work.

Demand source: open source

Work settings

SettingTypical roleMain constraint
Hospital laboratoriesHistopathology, hematology, cytology and clinical pathology.Volume, accreditation and subspecialty mix differ by hospital.
Diagnostic chainsHigh-throughput laboratory work and reporting.Scale, automation and quality systems are central.
Independent laboratoryPossible but capital, regulation, accreditation and referral relationships matter.Economics differ sharply from salaried pathology.
Academia / researchTeaching, cancer pathology, molecular research and biobanking.Strong research fit.
Pharma / diagnosticsBiomarkers, companion diagnostics, clinical trials, medical affairs and lab platforms.Growing interface with precision medicine.

Practice economics

Pathology can be lucrative in ownership or leadership models, but laboratory economics are capital- and volume-sensitive. Salaried reporting roles differ from owning a diagnostic business. Automation can reduce manual workload while increasing the value of subspecialty interpretation, molecular diagnostics and quality leadership.

No generic salary range is shown unless a dated source supports the role, geography and sector.

Training capacity

3,343NMC seats in the 29 Sep 2026 matrix for this route.
192 post-MBBS · 102 post-diplomaCurrent NBEMS DNB seats: post-MBBS and post-diploma.

State and college counts are shown only where the source rows can be checked exactly.

Higher-training and focused routes

Onco-PathologyRecognized DM route in the current NMC matrix.
Molecular pathologyFocused training and laboratory career route.
HematopathologyFocused subspecialty route.
NeuropathologyFocused academic/subspecialty route.
Renal pathologyFocused subspecialty route.
Laboratory managementQuality, accreditation and enterprise leadership pathway.

Eligibility rules can change. The current NMC/NBEMS/NEET-SS bulletin governs formal feeder eligibility.

Research, industry and teaching

Medical affairsOncology, biomarkers, diagnostics and companion-diagnostic portfolios.
Clinical trialsCentral lab, tissue biomarkers, response assessment and translational research.
Teaching / CMEStrong demand in morphology, molecular diagnostics and quality systems.
Diagnostics industryLaboratory automation, digital pathology, scanners and AI platforms.

AI applications and workflow

Digital pathology enables whole-slide imaging, remote reporting and AI-assisted analysis. A 2026 India-focused review highlights opportunities in primary diagnosis, second opinions, education and quality assurance, while also noting infrastructure, cost, data security and adoption barriers.

Regional variation

Cancer registry coverage, diagnostic infrastructure and pathologist distribution vary substantially by state and city. Cancer burden therefore needs to be read alongside lab density, pathology workforce and oncology infrastructure.

Disease burden, workforce, infrastructure and private-market conditions are reported separately; one is not used as a proxy for another.

Regional figures: open source

Current openings

References